Protective effect of morin on dimethylnitrosamine-induced hepatic fibrosis in rats

Digestive Diseases and Sciences

Volumn 54, Issue 4, 2009, Pages 782-788

  Lee, Hee Seung ^a   Jung, Kyung Hee ^a   Park, In Suh ^a   Kwon, Sung Won ^b   Lee, Don Haeng ^a   Hong, Soon Sun ^a  

^a Inha University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Antioxidant; Dimethylnitrosamine; Hepatic fibrosis; Morin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLLAGEN FIBER; COLLAGEN TYPE 1; DIMETHYLNITROSAMINE; MESSENGER RNA; MORIN; TRANSFORMING GROWTH FACTOR BETA1; ACTIN; ANTIOXIDANT; FLAVONOID; SMOOTH MUSCLE ACTIN, RAT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FIBRINOLYSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER PROTECTION; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TEST; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYTOTHERAPY; SPRAGUE DAWLEY RAT;

ACTINS; ANIMALS; ANTIOXIDANTS; BODY WEIGHT; COLLAGEN TYPE I; DIMETHYLNITROSAMINE; FLAVONOIDS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; ORGAN SIZE; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 63249101797     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0404-x     Document Type: Article

References (28)

1. SS Wijeratne MM Abou-Zaid F Shahidi 2006 Antioxidant polyphenols in almond and its coproducts J Agric Food Chem 54 312 318 10.1021/jf051692j (Pubitemid 43301245)
2. BB Aggarwal S Shishodia 2006 Molecular targets of dietary agents for prevention and therapy of cancer Biochem Pharmacol 71 1397 1421 10.1016/j.bcp.2006.02.009
3. MX Xie M Long Y Liu C Qin YD Wang 2006 Characterization of the interaction between human serum albumin and morin Biochim Biophys Acta 1760 1184 1191 (Pubitemid 43928259)
4. TW Wu LH Zeng J Wu KP Fung 1993 Morin hydrate is a plant-derived and antioxidant-based hepatoprotector Life Sci 53 PL213 PL218 10.1016/0024-3205(93) 90266-6 (Pubitemid 223041988)
5. TW Wu LH Zeng J Wu KP Fung 1994 Morin: a wood pigment that protects three types of human cells in the cardiovascular system against oxyradical damage Biochem Pharmacol 47 1099 1103 10.1016/0006-2952(94)90424-3 (Pubitemid 24103845)
6. Z Yu WP Fong Cheng CH 2006 The dual actions of morin (3, 5, 7, 2, 4-pentahydroxyflavone) as a hypouricemic agent. Uricosuric effect and xanthine oxidase inhibitory activity J Pharmacol Exp Ther 316 169 175 10.1124/jpet.105.092684 (Pubitemid 43000578)
7. HM Kuo LS Chang YL Lin HF Lu JS Yang JH Lee 2007 Morin inhibits the growth of human leukemia hl-60 cells via cell cycle arrest and induction of apoptosis through mitochondria dependent pathway Anticancer Res 27 395 405
8. SK Manna RS Aggarwal G Sethi BB Aggarwal GT Ramesh 2007 Morin (3, 5, 7, 2, 4-pentahydroxyflavone) abolishes nuclear factor-kappab activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappab-regulated gene expression and up-regulation of apoptosis Clin Cancer Res 13 2290 2297 10.1158/1078-0432.CCR-06-2394 (Pubitemid 46649899)
9. MJ Laughton PJ Evans MA Moroney JR Hoult B Halliwell 1991 Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability Biochem Pharmacol 42 1673 1681 10.1016/0006-2952(91)90501-U
10. K Kawabata T Tanaka S Honjo M Kakumoto A Hara H Makita 1999 Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis Int J Cancer 83 381 386 10.1002/(SICI)1097-0215(19991029) 83:3<381::AID-IJC14>3.0.CO;2-X (Pubitemid 29455762)
11. CY Hsiang SL Wu TY Ho 2005 Morin inhibits 12-o-tetradecanoylphorbol-13- acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression Biochem Pharmacol 69 1603 1611 10.1016/j.bcp. 2005.03.008 (Pubitemid 40719497)
12. SL Friedman 2003 Liver fibrosis-from bench to bedside J Hepatol 38 Suppl 1 S38 S53 10.1016/S0168-8278(02)00429-4 (Pubitemid 39658635)
13. R Bataller DA Brenner 2005 Liver fibrosis J Clin Invest 115 209 218 (Pubitemid 40385459)
14. M Pinzani F Marra 2001 Cytokine receptors and signaling in hepatic stellate cells Semin Liver Dis 21 397 416 10.1055/s-2001-17554 (Pubitemid 32923768)
15. S Lotersztajn B Julien F Teixeira-Clerc P Grenard A Mallat 2005 Hepatic fibrosis: molecular mechanisms and drug targets Annu Rev Pharmacol Toxicol 45 605 628 10.1146/annurev.pharmtox.45.120403.095906 (Pubitemid 40261819)
16. H Yamazaki Y Inui CH Yun FP Guengerich T Shimada 1992 Cytochrome p450 2e1 and 2a6 enzymes as major catalysts for metabolic activation of n-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes Carcinogenesis 13 1789 1794 10.1093/carcin/13.10.1789
17. AA Bertelli L Giovannini R Stradi A Bertelli JP Tillement 1996 Plasma, urine and tissue levels of trans- and cis-resveratrol (3, 4, 5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats Int J Tissue React 18 67 71 (Pubitemid 27121767)
18. MH Lee S Yoon JO Moon 2004 The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats Biol Pharm Bull 27 72 76 10.1248/bpb.27.72 (Pubitemid 41656676)
19. L Ala-Kokko T Pihlajaniemi JC Myers KI Kivirikko ER Savolainen 1987 Gene expression of type i, iii and iv collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat Biochem J 244 75 79 (Pubitemid 17098811)
20. C Pilette MC Rousselet P Bedossa D Chappard F Oberti H Rifflet 1998 Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers J Hepatol 28 439 446 10.1016/S0168-8278(98)80318-8 (Pubitemid 28133548)
21. SI Aleynik MA Leo X Ma MK Aleynik CS Lieber 1997 Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis J Hepatol 27 554 561 10.1016/S0168-8278(97)80361-3 (Pubitemid 27390904)
22. ER Savolainen D Brocks L Ala-Kokko KI Kivirikko 1988 Serum concentrations of the n-terminal propeptide of type iii procollagen and two type iv collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis Biochem J 249 753 757 (Pubitemid 18042794)
23. SA Jenkins A Grandison JN Baxter DW Day I Taylor R Shields 1985 A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat J Hepatol 1 489 499 10.1016/S0168-8278(85)80747-9 (Pubitemid 15012681)
24. M Bauer D Schuppan 2001 TGFbeta1 in liver fibrosis Time to change paradigms? FEBS Lett 502 1 3 10.1016/S0014-5793(01)02655-2 (Pubitemid 32722049)
25. G Giannelli S Antonaci 2005 Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection Histol Histopathol 20 939 944 (Pubitemid 40932611)
26. RG Wells 2005 The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis J Clin Gastroenterol 39 S158 S161 10.1097/01.mcg.0000155516.02468.0f (Pubitemid 40397030)
27. B Schnabl YO Kweon JP Frederick XF Wang RA Rippe DA Brenner 2001 The role of smad3 in mediating mouse hepatic stellate cell activation Hepatology 34 89 100 10.1053/jhep. 2001.25349 (Pubitemid 32591487)
28. AM Gressner R Weiskirchen K Breitkopf S Dooley 2002 Roles of TGF-beta in hepatic fibrosis Front Biosci 7 d793 d807 10.2741/gressner